JPRN-UMIN000008989已完成未知
Effect and safety of conversion from Candesartan to Azilsartan in renal transplant recipeints - Conversion to Azilsartan in kidney trasnplant recipients
Soryukai Inoue Hospital0 个研究点目标入组 40 人开始时间: 2012年10月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Past medical history of hypersensitivity to azilsartan 2)Pregnant,lactating,and possibly pregnant women and those planning to become pregnant 3)Judged as ineligible by clinical investigators
研究者
相似试验
已完成
不适用
agasaki Investigation of Candesartan Effects -the Comparison Between an Increased Candesartan and the additional DiureticsHypertensionJPRN-UMIN000003978Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences100
已完成
不适用
Candesartan may prevent aneurysmal changes in the residual native aorta after thoracic aortic aneurysm surgeryThoracic aortic aneurysmJPRN-UMIN000000756Graduate School of Medicine, Tohoku University150
进行中（未招募）
不适用
Candesartan added Treatment for Optimisation of Heart Failure (HF) Therapy - Effects on BNP and other HF associated Parameters.An open, non-controlled and multicentre trialHeart failureEUCTR2004-003962-14-DETakeda Pharma GmbH
进行中（未招募）
不适用
Candesartan added” therapy for treatment optimization of symptomatic heart failure with diastolic dysfunction in diabetic and hypertensive patients. A randomized, placebo-controlled, double-blind, parallel-group and multicentre clinical phase III study investigating the effects on NT-proBNP over 6 months. - CAN-DHFSymptomatic heart failure with diastolic dysfunction in diabetic and hypertensive patientsMedDRA version: 9.1Level: LLTClassification code 10019279Term: Heart failureMedDRA version: 9.1Level: LLTClassification code 10052337Term: Diastolic dysfunctionEUCTR2007-003070-26-DETakeda Pharma GmbH
进行中（未招募）
1 期
Comparative Effects of Telmisartan and Candesartan on glucose metabolism in patients with chronic heart failure - Sartans and glucosemetabolismEUCTR2005-002109-22-ATMedical University of Vienna99